Results
1 -
10 of
79
(Click
here to explore results)
- Biological targets and mechanisms of action of natural products from marine cyanobacteria. Lilibeth A. Salvador-Reyes, Hendrik Luesch
, Nat. Prod. Rep.
, 2015
, 32
, 478
- Dolastatins 24: synthesis of (–)-dolastatin 10. X-Ray molecular structure of N,N-dimethylvalyl-valyl-dolaisoleuine tert-butyl ester. George R. Pettit, Jayaram K. Srirangam, Sheo Bux Singh, Michael D. Williams, Delbert L. Herald, József Barkóczy, Darko Kantoci, Fiona Hogan
, J. Chem. Soc., Perkin Trans. 1
, 1996
, 859
- A practical approach to asymmetric synthesis of dolastatin 10. Wen Zhou, Xiao-Di Nie, Yu Zhang, Chang-Mei Si, Zhu Zhou, Xun Sun, Bang-Guo Wei
, Org. Biomol. Chem.
, 2017
, 15
, 6119
- A diastereoselective approach to amino alcohols and application for divergent synthesis of dolastatin 10. Xiao-Di Nie, Zhuo-Ya Mao, Wen Zhou, Chang-Mei Si, Bang-Guo Wei, Guo-Qiang Lin
, Org. Chem. Front.
, 2020
, 7
, 76
- Convergent synthesis of hydrophilic monomethyl dolastatin 10 based drug linkers for antibody–drug conjugation. Kanwen Yang, Bo Chen, Diego A. Gianolio, James E. Stefano, Michelle Busch, Charlene Manning, Kim Alving, Richard C. Gregory, William H. Brondyk, Robert J. Miller, Pradeep K. Dhal
, Org. Biomol. Chem.
, 2019
, 17
, 8115
- Cytotoxic and antitumor peptides as novel chemotherapeutics. Xin Luan, Ye Wu, Yi-Wen Shen, Hong Zhang, Yu-Dong Zhou, Hong-Zhuan Chen, Dale G. Nagle, Wei-Dong Zhang
, Nat. Prod. Rep.
, 2021
, 38
, 7
- Recent advances in the synthesis of naturally occurring pyrrolidines, pyrrolizidines and indolizidine alkaloids using proline as a unique chiral synthon. Chinmay Bhat, Santosh G. Tilve
, RSC Adv.
, 2014
, 4
, 5405
- A straightforward click-approach towards pretubulysin-analogues. Jens L. Burkhart, Uli Kazmaier
, RSC Adv.
, 2012
, 2
, 3785
- Dolastatins 23: stereospecific synthesis of dolaisoleuine. George R. Pettit, Douglas D. Burkett, Michael D. Williams
, J. Chem. Soc., Perkin Trans. 1
, 1996
, 853
- The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics. Hans-Peter Gerber, Frank E. Koehn, Robert T. Abraham
, Nat. Prod. Rep.
, 2013
, 30
, 625